Stocktoria
CapForce Inc. CFOR
OTC · stock · Services-Medical Laboratories · website · IPO 2015-05-05
CapForce Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $30.2M | $5.2M | $3.4M | $2.6M | $4.3M | $4.2M | $3.5M | $2.9M | $3.2M | $4.0M |
| R&D expense | $6,585 | $48,820 | $4.7M | $8.2M | $10.9M | $10.0M | $5.1M | $5.7M | $6.9M | $8.6M |
| Operating income | $24.0M | $324,717 | -$30.7M | -$34.6M | -$23.3M | -$22.7M | -$12.3M | -$13.2M | -$15.3M | -$19.0M |
| Interest expense | $11,245 | $7,555 | $1.8M | $3.3M | $4.8M | $3.4M | $187,549 | $191,195 | $233,505 | $143,347 |
| Income tax | $813,809 | $176,662 | — | — | $43,828 | $132,403 | $0 | $0 | $0 | $0 |
| Net income | $23.6M | $12.0M | -$32.7M | -$37.3M | -$34.8M | -$26.2M | -$12.4M | -$13.4M | -$15.4M | -$19.2M |
| EPS (diluted) | $2.32 | $2.30 | $-41.47 | $-152.70 | $-22.89 | — | — | — | — | — |
| Operating cash flow | -$1.2M | -$4.9M | -$14.3M | -$20.4M | -$21.5M | -$23.4M | -$11.5M | -$11.1M | -$14.3M | -$17.3M |
| Free cash flow | -$1.2M | — | -$15.1M | -$21.0M | -$23.5M | -$23.5M | -$11.5M | -$11.2M | -$14.6M | -$17.4M |
| Cash & equivalents | $531,277 | $1.3M | $1.2M | $7.4M | $36.1M | $13.4M | $2.7M | $4.6M | $1.8M | $4.1M |
| Inventory | — | — | — | $3.6M | $4.7M | $3.2M | $473,030 | $543,747 | $533,425 | $692,368 |
| Total assets | $38.1M | $9.9M | $1.9M | $25.8M | $71.7M | $49.8M | $10.4M | $9.0M | $6.6M | $9.0M |
| Total liabilities | $6.2M | $2.5M | $13.4M | $18.2M | $30.4M | $28.6M | $6.1M | $5.6M | $5.2M | $5.8M |
| Shareholders' equity | $31.9M | $7.4M | -$11.6M | $7.6M | $41.2M | $21.2M | $4.3M | $3.3M | $1.4M | $3.2M |
Growth · year-over-year · Revenue CAGR 25.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +481.2% | +52.0% | +31.1% | -39.5% | +2.2% | +20.5% | +18.7% | -8.2% | -20.2% | +27.5% |
| Net income growth | +97.0% | — | — | — | — | — | — | — | — | — |
| EPS growth | +0.9% | — | — | — | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.